β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway

Cardiovascular Research

Volumn 96, Issue 2, 2012, Pages 255-264

  Vidal, Marie ^a   Wieland, Thomas ^c   Lohse, Martin J ^a,b   Lorenz, Kristina ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adrenergic receptor; Cardiac hypertrophy; Erk1 2; G protein; G protein subunits; Phosphorylation

Indexed keywords

BETA ADRENERGIC RECEPTOR; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT;

ADRENERGIC BETA-AGONISTS; ANIMALS; CARDIOMEGALY; CERCOPITHECUS AETHIOPS; COS CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; ISOPROTERENOL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA;

EID: 84867711595     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs249     Document Type: Article

References (48)

1. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:721-730.
2. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of b-adrenergic signaling in heart failure? Circ Res 2003;93:896-906.
3. Molkentin JD, Dowern GW 2nd. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 2001;63:391-426.
4. Port JD, Bristow MR. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure. J Mol Cell Cardiol 2001;33:887-905.
5. Feldman DS, Carnes CA, Abraham WT, Bristow MR. Mechanisms of disease: b-adrenergic receptors-alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med 2005;2:475-483.
6. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in b1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 1999;96: 7059-7064.
7. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK et al. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GSa overexpression. Circ Res 1996;78:517-524.
8. Antos CL, Frey N, Marx SO, Reiken S, Gaburjakova M, Richardson JA et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase A. Circ Res 2001;89:997-1004.
9. Tepe NM, Lorenz JN, Yatani A, Dash R, Kranias EG, Dorn GW 2nd et al. Altering the receptor-effector ratio by transgenic overexpression of type V adenylyl cyclase: enhanced basal catalytic activity and function without increased cardiomyocyte b-adrenergic signalling. Biochemistry 1999;38:16706-16713.
10. Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, Zhou JY et al. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation 1999;99:3099-3102.
11. Shan J, Betzenhauser MJ, Kushnir A, Reiken S, Meli AC, Wronska A et al. Role of chronic ryanodine receptor phosphorylation in heart failure and b-adrenergic receptor blockade in mice. J Clin Invest 2010;120:4375-4387.
12. Lorenz K, Schmitt JP, Schmitteckert EM, Lohse MJ. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy. Nat Med 2009;15:75-83.
13. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003;426:574-579.
14. Buitrago M, Lorenz K, Maass AH, Oberdorf-Maass S, Keller U, Schmitteckert EM et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 2005;11:837-844.
15. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995;9:726-735.
16. Thomas WG, Brandenburger Y, Autelitano DJ, Pham T, Qian H, Hannan RD. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ Res 2002;90:135-142.
17. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 1996;314:115-121.
18. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med (Berl) 1998;76:725-746.
19. Ueyama T, Kawashima S, Sakoda T, Rikitake Y, Ishida T, Kawai M et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. J Mol Cell Cardiol 2000;32:947-960.
20. Heximer SP, Watson N, Linder ME, Blumer KJ, Hepler Jr. RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci USA 1997;94:14389-14393.
21. Hilal-Dandan R, Means CK, Gustafsson AB, Morissette M, Adams JW, Brunton LL et al. Lysophosphatidic acid induces hypertrophy of neonatal cardiac myocytes via activation of Gi and Rho. J Mol Cell Cardiol 2004;36:481-493.
22. Henaff M, Hatem SN, Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 2000;58:1546-1553.
23. Zheng J, Shen H, Xiong Y, Yang X, He J. The b1-adrenergic receptor mediates extracellular signal-regulated kinase activation via Gas. Amino Acids 2010;38:75-84.
24. Shan J, Kushnir A, Betzenhauser MJ, Reiken S, Li J, Lehnart SE et al. Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice. J Clin Invest 2010;120:4388-4398.
25. Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H et al. Ca2+-and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest 2007;117:2431-2444.
26. Kedzierski RM, Grayburn PA, Kisanuki YY, Williams CS, Hammer RE, Richardson JA et al. Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol 2003;23:8226-8232.
27. Molkentin JD, Robbins J. With great power comes great responsibility: Using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol 2009;46:130-136.
28. Kimura TE, Jin J, Zi M, Prehar S, Liu W, Oceandy D et al. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart. Circ Res 2010;106: 961-970.
29. van Berlo JH, Elrod JW, Aronow BJ, Pu WT, Molkentin JD. Serine 105 phosphorylation of transcription factor GATA4 is necessary for stress-induced cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 2011;108:12331-12336.
30. Bogoyevitch MA, Sugden PH. The role of protein kinases in adaptational growth of the heart. Int J Biochem Cell Biol 1996;28:1-12.
31. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006;7:589-600.
32. Kehat I, Molkentin JD. Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci 2010;1188:96-102.
33. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000;19:6341-6350.
34. Kehat I, Davis J, Tiburcy M, Accornero F, Saba-El-Leil MK, Maillet M et al. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth. Circ Res 2011;108:176-183.
35. Haystead TA, Dent P, Wu J, Haystead CM, Sturgill TW. Ordered phosphorylation of p42mapk by MAP kinase kinase. FEBS Lett 1992;306:17-22.
36. Lorenz K, Schmitt JP, Vidal M, Lohse MJ. Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 2009;41:2351-2355.
37. Khokhlatchev AV, Canagarajah B, Wilsbacher J, Robinson M, Atkinson M, Goldsmith E et al. Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 1998;93:605-615.
38. Caunt CJ, McArdle CA. ERK phosphorylation and nuclear accumulation: insights from single-cell imaging. Biochem Soc Trans 2012;40:224-229.
39. Chuderland D, Konson A, Seger R. Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 2008;31:850-861.
40. Métrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E et al. Epac mediates b-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 2008;102: 959-965.
41. Nunn C, Zou MX, Sobiesiak AJ, Roy AA, Kirshenbaum LA, Chidiac P. RGS2 inhibits b-adrenergic receptor-induced cardiomyocyte hypertrophy. Cell Signal 2010;22: 1231-1239.
42. Hoch B, Meyer R, Hetzer R, Krause EG, Karczewski P. Identification and expression of d-isoforms of the multifunctional Ca2 +calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res 1999;84:713-721.
43. Kirchhefer U, Schmitz W, Scholz H, Neumann J. Activity of cAMP-dependent protein kinase and Ca2 +calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res 1999;42:254-261.
44. Grimm M, Brown JH. b-Adrenergic receptor signaling in the heart: role of CaMKII. J Mol Cell Cardiol 2010;48:322-330.
45. Zhang T, Kohlhaas M, Backs J, Mishra S, Phillips W, Dybkova N et al. CaMKIId isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses. J Biol Chem 2007;282:35078-35087.
46. Münzel F, Mühlhäuser U, Zimmermann WH, Didié M, Schneiderbanger K, Schubert P et al. Endothelin-1 and isoprenaline co-stimulation causes contractile failure which is partially reversed by MEK inhibition. Cardiovasc Res 2005;68:464-474.
47. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000;86:692-699.
48. Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN et al. MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 2004;109:1938-1941.